Influence of acute normovolaemic haemodilution on the dose-response relationship and time course of action of cisatracurium besylate

Our results demonstrated that unlike other previously reported neuromuscular blocking drugs, ANH did not alter cisatracurium potency. Thus, cisatracurium would be the neuromuscular blocking drug of choice in patients who undergo surgery with ANH, as no dose adjustments are required.